Back to top
more

Walgreens Boots Alliance (WBA)

(Real Time Quote from BATS)

$11.66 USD

11.66
6,075,311

+0.02 (0.17%)

Updated Aug 4, 2025 02:56 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (96 out of 246)

Industry: Retail - Pharmacies and Drug Stores

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here's Why Walgreens Boots Alliance (WBA) Fell More Than Broader Market

by Zacks Equity Research

In the closing of the recent trading day, Walgreens Boots Alliance (WBA) stood at $9.73, denoting a -1.12% change from the preceding trading day.

Zacks Equity Research

Macy's (M) Lags Q3 Earnings Estimates

by Zacks Equity Research

Macy's (M) delivered earnings and revenue surprises of -42.86% and 0.28%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Is Invesco High Yield Equity Dividend Achievers ETF (PEY) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for PEY

Urmimala Biswas headshot

CVS' High Utilization & MBR to Cut 2024 Profits: Is the Stock a Sell?

by Urmimala Biswas

The persistently elevated utilization of medical services is significantly putting pressure on CVS Health's Health Care Benefits segment.

Zacks Equity Research

Walgreens Boots Alliance (WBA) Outperforms Broader Market: What You Need to Know

by Zacks Equity Research

Walgreens Boots Alliance (WBA) concluded the recent trading session at $8.56, signifying a +1.06% move from its prior day's close.

Zacks Equity Research

GMS (GMS) Misses Q2 Earnings Estimates

by Zacks Equity Research

GMS (GMS) delivered earnings and revenue surprises of -10.62% and 1.12%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

These 2 Retail and Wholesale Stocks Could Beat Earnings: Why They Should Be on Your Radar

by Zacks Equity Research

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Zacks Equity Research

Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $9.02, indicating a -0.44% shift from the previous trading day.

Tracey Ryniec headshot

Should You Buy More Shares of Your Loser Stocks?

by Tracey Ryniec

Intel, Disney and 3 others have struggled the last 5 years. Should long-time investors double down?

Zacks Equity Research

Walgreens Boots Alliance (WBA) Stock Moves -0.6%: What You Should Know

by Zacks Equity Research

Walgreens Boots Alliance (WBA) closed the most recent trading day at $8.24, moving -0.6% from the previous trading session.

Zacks Equity Research

Walgreens (WBA) Down 18.4% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Walgreens (WBA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Walgreens Boots Alliance (WBA) Surpasses Market Returns: Some Facts Worth Knowing

by Zacks Equity Research

The latest trading day saw Walgreens Boots Alliance (WBA) settling at $9.03, representing a +0.22% change from its previous close.

Urmimala Biswas headshot

Estimates for CVS Southbound After Rocky Q3: How to Play the Stock

by Urmimala Biswas

CVS Health expects the elevated levels of utilization to continue to put pressure on its 2024 performance and as a result could not provide an outlook for 2024.

Zacks Equity Research

Veeva Systems Collaborates With Walgreens to Improve Patient Outcomes

by Zacks Equity Research

VEEV partners with Walgreens to provide better patient outcomes to life sciences companies.

Urmimala Biswas headshot

CVS Q3 Estimates Plunge Before Earnings Release: How to Play the Stock

by Urmimala Biswas

CVS Health faces outpatient and supplemental benefits pressure within Health Care Benefits.

Urmimala Biswas headshot

WBA Stock Up 16% on New Restructuring Strategy: How to Play the Stock

by Urmimala Biswas

Walgreens Boots is currently going all out to reform its pharmacy model by aggressively liquidating its unprofitable stores and businesses.

Zacks Equity Research

Company News for Oct 16, 2024

by Zacks Equity Research

Companies In The Article Are: WOLF, WBA, SCHW, PNC

Zacks Equity Research

WBA Stock Up on Q4 Earnings & Revenues Beat, Unveils Strategic Action

by Zacks Equity Research

Walgreens reports better-than-expected earnings and revenues in the fourth quarter of fiscal 2024.

Zacks Equity Research

Earnings Data Deluge

by Zacks Equity Research

Earnings Data Deluge.

Mark Vickery headshot

Q3 Earnings Beats: C, GS, BAC, JNJ, WBA; Empire State Lower

by Mark Vickery

While Goldman Sachs (GS) and Citi (C) both impressed on earnings this morning, Walgreens (WBA) looks to bounce back.

Zacks Equity Research

Compared to Estimates, Walgreens (WBA) Q4 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Walgreens (WBA) give a sense of how the business performed in the quarter ended August 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Walgreens Boots Alliance (WBA) Surpasses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Walgreens (WBA) delivered earnings and revenue surprises of 8.33% and 5.07%, respectively, for the quarter ended August 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Q3 Earnings Results of U.S. Corporate Giants in Focus

by Zacks Equity Research

Q3 Earnings Results of U.S. Corporate Giants in Focus.

Mark Vickery headshot

Bank Holiday Ahead of Busy Stock Trading Week

by Mark Vickery

Despite today's day off from econ metrics, we see a pretty busy week ahead.

Zacks Equity Research

Unlocking Q4 Potential of Walgreens (WBA): Exploring Wall Street Estimates for Key Metrics

by Zacks Equity Research

Besides Wall Street's top -and-bottom-line estimates for Walgreens (WBA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended August 2024.